Cherwell Offers Process Validation Advice and Solutions at PHSS 2014
Cherwell Laboratories, specialist suppliers of products for environmental monitoring and process validation, have confirmed their support for the Pharmaceutical & Healthcare Sciences Society (PHSS) Annual Conference 2014.
Taking place on the 11–12 September 2014 at University College London UCL, School of Pharmacy, the conference will focus on “Processing challenging Pharmaceutical, Biopharmaceutical and Therapy products to GMP: Managing compliance, control, monitoring and efficiency challenges”. Experts from Cherwell will be available to offer practical microbiological advice and solutions.
With over 40 years’ experience, Cherwell has a reputation for providing high-quality solutions to meet the environmental monitoring and process validation requirements of the pharmaceutical and healthcare industries. The product range, which includes Redipor prepared media, SAS microbial air samplers and biological indicators, has been developed in response to changes in regulatory and customer-specific requirements.
Andrew Barrow, Sales Manager commented: “At Cherwell, we understand the importance of keeping up-to-date with the constantly changing regulatory, product and processing environments.” He added, “Our attendance at events, such as the PHSS Annual Conference, helps us to maintain our own levels of knowledge and offer expert advice on products and applications”.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance